Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Rehwinkel

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Cancer Immunology Research|March 25, 2020
Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer CellsGennaro Prota, Uzi Gileadi, Margarida Rei, et al.
Nature Microbiology|July 30, 2025
Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infectionVirginie Girault, Alexey Stukalov, Madalina Elena Carter-Timofte, et al.
RMD Open|March 2, 2023
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to considerAgata Burska, Javier Rodríguez-Carrio, Robert Biesen, et al.
The EMBO Journal|January 27, 2017
A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophagesPetra Mlcochova, Katherine A Sutherland, Sarah A Watters, et al.
Science (New York, N.Y.)|January 15, 2026
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesityDanhui Liu, Chuanli Zhou, Xiaochen Wang, et al.
Nature|July 27, 2018
Mitochondrial double-stranded RNA triggers antiviral signalling in humansAshish Dhir, Somdutta Dhir, Lukasz S Borowski, et al.
RMD Open|March 7, 2023
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to considerJavier Rodríguez-Carrio, Agata Burska, P G Conaghan, et al.
Annals of the Rheumatic Diseases|March 1, 2023
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practiceJavier Rodríguez-Carrio, Agata Burska, Philip G Conaghan, et al.
EMBO Reports|October 21, 2022
Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1Ruoshi Peng, Chris Kedong Wang, Xuan Wang-Kan, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replicationTobias Moll, Valerie Odon, Calum Harvey, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Cancer Immunology Research|March 25, 2020
Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer CellsGennaro Prota, Uzi Gileadi, Margarida Rei, et al.
Nature Microbiology|July 30, 2025
Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infectionVirginie Girault, Alexey Stukalov, Madalina Elena Carter-Timofte, et al.
RMD Open|March 2, 2023
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to considerAgata Burska, Javier Rodríguez-Carrio, Robert Biesen, et al.
The EMBO Journal|January 27, 2017
A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophagesPetra Mlcochova, Katherine A Sutherland, Sarah A Watters, et al.
Science (New York, N.Y.)|January 15, 2026
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesityDanhui Liu, Chuanli Zhou, Xiaochen Wang, et al.
Nature|July 27, 2018
Mitochondrial double-stranded RNA triggers antiviral signalling in humansAshish Dhir, Somdutta Dhir, Lukasz S Borowski, et al.
RMD Open|March 7, 2023
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to considerJavier Rodríguez-Carrio, Agata Burska, P G Conaghan, et al.
Annals of the Rheumatic Diseases|March 1, 2023
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practiceJavier Rodríguez-Carrio, Agata Burska, Philip G Conaghan, et al.
EMBO Reports|October 21, 2022
Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1Ruoshi Peng, Chris Kedong Wang, Xuan Wang-Kan, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replicationTobias Moll, Valerie Odon, Calum Harvey, et al.
Pageof 10